METHODS: This is a retrospective multicentre study of children who attended NI clinics between January 2022 and July 2023. Data were collected before and 1 month after receiving a low-energy, partially hydrolysed enteral formula (0.6 kcal/mL) on demographic data (age, sex, ethnicity and NI diagnosis), anthropometric measurements (weight, height, weight-for-age Z-score, height-for-age Z-score, body mass index [BMI] Z-score) and feed regimen (feed volume, total fluids and type of formula/supplements).
RESULTS: Dietitians collected data on 28 children, the median age was 7 years (interquartile range [IQR] 3, 8). The most frequently recorded NI was cerebral palsy, in 13 of 28 children (48%). Before the formula switch, the most frequently reported gastrointestinal symptom was constipation, in 13 of 28 children. Within 1 month of switching to a low-energy, hydrolysed formula, 10 of the 13 (77%) children reported an improvement in constipation. Before the formula switch, all 28 children were experiencing excessive weight gain. After the formula was switched to low-energy, hydrolysed formula, dietitians reported that 20 of the 28 (76%) children\'s weight either stabilised or reduced after 1 month. There was no statistically significant difference in weight-for-age Z-score or BMI Z-scores postswitch of formula (p-value 0.1 and 0.09, respectively). Fibre intake increased significantly from 3.3 to 8.1 g/day (p-value < 0.01) after formula switch. The number of children whose feed regimens were simplified after switching to a low-energy, partially hydrolysed formula was 24 of 28 (91%).
CONCLUSIONS: Children with an NI who have gastrointestinal symptoms may benefit from a low-energy, hydrolysed enteral formula to maximise feed tolerance and promote healthy weight gain. In addition, changing to a low-energy, hydrolysed formula may simplify feed regimens by eliminating the need for additional electrolytes, multivitamins and fluid boluses. Healthcare professionals should be knowledgeable about the effectiveness and availability of a low-energy, hydrolysed formula.
方法:这是一项针对2022年1月至2023年7月期间在NI诊所就诊的儿童的回顾性多中心研究。数据收集之前和接受低能量,人口统计数据上的部分水解肠内配方(0.6千卡/毫升)(年龄,性别,种族和NI诊断),人体测量(体重,高度,年龄体重Z评分,身高年龄Z分,体重指数[BMI]Z评分)和饲料方案(饲料量,总液体和配方/补充剂的类型)。
结果:营养师收集了28名儿童的数据,中位年龄为7岁(四分位距[IQR]3,8).最常记录的NI是脑瘫,28名儿童中有13名(48%)。在公式转换之前,最常见的胃肠道症状是便秘,28个孩子中的13个。在切换到低能耗的1个月内,水解配方,13名儿童中有10名(77%)报告便秘有所改善。在公式转换之前,所有28名儿童都经历了过多的体重增加.配方切换到低能量后,水解配方,营养师报告说,28名儿童中有20名(76%)的体重在1个月后稳定或减少。公式转换后,年龄体重Z评分或BMIZ评分无统计学差异(p值分别为0.1和0.09)。配方转换后,纤维摄入量从3.3g/天显着增加到8.1g/天(p值<0.01)。改用低能量喂养后简化喂养方案的儿童数量,部分水解的配方是28个中的24个(91%)。
结论:有胃肠道症状的NI患儿可能会从低能量治疗中获益,水解肠内配方,以最大限度地提高饲料耐受性和促进健康的体重增加。此外,换成低能耗的,水解配方可以通过消除对额外电解质的需求来简化饲料方案,多种维生素和液体丸剂。医疗保健专业人员应该了解低能耗的有效性和可用性,水解配方。